Mild Reaction Is a Positive<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />4/4/2008 8:46 AM EDT<br /><br />The job's numbers are certainly worse than expected, and we have had big revisions downward for January and February, but the market reaction isn't severe at all considering how much we were up before the numbers hit. <br /> <br />Overall, the market does not seem that concerned about the numbers at the moment. They certainly seem to indicate that we are falling into a recession, but the only ones who aren't already talking about that are the government officials who think they have to put a positive spin on things to keep the mood upbeat. <br /><br />We'll see how things progress, but the rather mild reaction to bad numbers is a positive, and if we don't see more selling pressure, that is going to scare shorts and drag in more sidelined cash. <br /><br /><br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: REST +23.1%, BTH +14.0%, MOS +7.2%, WSCI +5.6%, SABA +1.9%... Select fertilizer/agriculture stocks showing strength following MOS earnings: SEED +5.9%, AGU +4.9%, TRA +3.8%, CF +3.2%, MON +2.6%, POT +2.3%... Other news: COCO +6.7% (still checking), DNDN +6.1% (still checking), LDK +5.3% (signs two additional wafer supply agreements and one polysilicon sourcing agreement), OMEX +5.0% (Spain's claim to one of Odyssey's shipwreck cases dismissed), USU +4.6% (showing continued upward momentum following yesterday's 30% surge), SHPGY +3.6% (up in sympathy with AZN and GSK), AZN +3.5% (extended the week's gains after the co said it will stop a trial of its cholesterol blockbuster drug Crestor early due to positive preliminary results), UBS +3.4% (former president pushes for a breakup - WSJ), ZOLL +3.1% (will replace TGIC in the S&P SmallCap 600 after the close on 4/7), CPL +2.6% (Cramer makes positive comments on MadMoney), ING +2.5% (still checking), GSK +2.0% (announces FDA has approved ROTARIX), FSLR +1.4% (Cramer makes positive comments on MadMoney), IDEV +1.3% (licenses European rights for VANTAS to Orion Corp)... Analyst upgrades: RTP +2.4% (upgraded to Outperform at Bernstein), BHP +1.9% (upgraded to Outperform at Bernstein), AUY +1.2% (upgraded to Buy at UBS).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: DMAN -8.4% (also downgraded to Mkt Perform at William Blair), RVBD -8.4% (also downgraded to Hold at Deutsche Bank), LWSN -6.3%, FDO -5.3%, CAE -1.4%... Other news: WX -4.2% (files an F-1 relating to a 10.12 mln share ADS offering; 4.26 ADS are being offered by the co and 5.86 mln ADS being offered by selling shareholders), MF -3.2% (checking for anything new; the stock gave up a good portion of its gains yesterday afternoon when WSJ reported that it is seeking financing alternatives), ZMH -3.0% (announced actions affecting its Ohio-based Orthopaedic Surgical Products Operation), AU -2.4% (revises production guidance for Q1), CFC -2.0% (Moody's cuts Countrywide's Bank Financial Strength rating to D; WSJ reports CFC faces downgrade if BofA deal falls through), DIOD -1.3% (to acquire Zetex plc)... Analyst downgrades: KSU -2.6% (downgraded to Neutral at UBS and downgraded to Market Perform from Outperform at BMO Capital), HMY -2.0% (downgraded to Sell at UBS), DELL -1.6% (downgraded to Neutral at tier 1 firm), TGA -1.0% (downgraded to Sector Perform at RBC), RDWR -1.0% (downgraded to Sector Perform at RBC), CSX -1.0% (downgraded to Neutral at Merrill).